Showing results (361-370 of 389) with videos related to

Sort By:
Pageof 39
Clinical Pharmacology and Therapeutics|May 10, 2017
Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' DiseaseT S Plantinga, P Arts, G H Knarren, et al.
The Lancet. Oncology|March 1, 2020
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 studyArthur J A T Braat, Rutger C G Bruijnen, Rob van Rooij, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2020
The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study GroupMedard F M van den Broek, Joanne M de Laat, Rachel S van Leeuwaarde, et al.
Gastrointestinal Endoscopy|December 21, 2014
EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1Sophie J van Asselt, Adrienne H Brouwers, Hendrik M van Dullemen, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 17, 2017
Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study GroupElfi B Conemans, Lodewijk A A Brosens, Gabriela M Raicu-Ionita, et al.
The Journal of Clinical Endocrinology and Metabolism|September 2, 2011
Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort studyD J F Stuijver, B van Zaane, R A Feelders, et al.
Annals of Surgical Oncology|May 18, 2022
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for RecurrenceE Merola, A Pascher, A Rinke, et al.
Endocrine-Related Cancer|June 22, 2014
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paragangliaThomas G Papathomas, Lindsey Oudijk, Ellen C Zwarthoff, et al.
European Journal of Endocrinology|January 10, 2015
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1Lutske Lodewijk, Pim J Bongers, Jakob W Kist, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapyR van der Pas, C de Bruin, F W G Leebeek, et al.
Pageof 39